Zdrowie i gospodarka · 23/04/2018
FDA Renews Arthritis Advisory Committee for 2 Additional Years
The FDA has renewed the Arthritis Advisory Committee for an additional 2 years, with the new charter set to expire on April 5, 2020.
Source: Federal Register — Food and Drug AdministrationOpen original release →